Semaglutide – a key ingredient in Ozempic and Wegovy – was associated with a lower risk of opioid overdose in patients with Type 2 diabetes and opioid use disorder, research shows.
Ontario family sues hospital and staff over son’s death
- yesterday, 7:01 AM
- globalnews.ca
- 0
No comments